Search
for
Sort by
Research 241–270 of 1000+
- Male androgenetic alopecia
- Medical treatment of hirsutism
- Primary cicatricial alopecia
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Case series of familial frontal fibrosing alopecia and a review of the literature
- Skin Manifestations of Insulin Resistance: From a Biochemical Stance to a Clinical Diagnosis and Management
- Finasteride-mediated hair regrowth and reversal of atrophy in a patient with frontal fibrosing alopecia
- Clinical and microscopic features of generalized discoid lupus erythematosus in dogs (10 cases)
- Cocaine-related bullous disease
- The antimycotic agent clotrimazole inhibits melanogenesis by accelerating ERK and PI3K-/Akt-mediated tyrosinase degradation
- The first case report of kerion-type scalp mycosis caused by Aspergillus protuberus
- Adverse Systemic Reaction to Dinitrochlorobenzene
- Tumor Necrosis Factor in Sepsis
- Hirsutism in Women.
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Clinical recognition and management of alopecia in women of color,
- Valproate-acid-induced cutaneous leukocytoclastic vasculitis.
- Medical treatments for balding in men.
- Treatment of pseudofolliculitis in trichotillomania improves outcome
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- SDRIFE Induced by Tofacitinib
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Dermatologic Care of the Transplant Patient
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Hyperandrogenism: Acne and Hirsutism
- Evaluation and Management of the Hair Loss Patient in the Primary Care Setting
- Hirsutism: Diagnosis and Treatment
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation